S&P 500   3,799.77
DOW   30,969.96
QQQ   315.86
S&P 500   3,799.77
DOW   30,969.96
QQQ   315.86
S&P 500   3,799.77
DOW   30,969.96
QQQ   315.86
S&P 500   3,799.77
DOW   30,969.96
QQQ   315.86
Log in
NASDAQ:ICAD

iCAD News Headlines

$13.27
+0.23 (+1.76 %)
(As of 01/19/2021 01:08 PM ET)
Add
Compare
Today's Range
$13.08
Now: $13.27
$13.48
50-Day Range
$9.34
MA: $12.68
$14.56
52-Week Range
$5.91
Now: $13.27
$15.31
Volume2,367 shs
Average Volume136,650 shs
Market Capitalization$305.12 million
P/E RatioN/A
Dividend YieldN/A
Beta1.3

Headlines

iCAD (NASDAQ ICAD) News Headlines Today

Source:
SourceHeadline
Head to Head Survey: Cerus (NASDAQ:CERS) & iCAD (NASDAQ:ICAD)Head to Head Survey: Cerus (NASDAQ:CERS) & iCAD (NASDAQ:ICAD)
americanbankingnews.com - January 15 at 12:47 PM
iCAD (NASDAQ:ICAD) Stock Price Passes Above 200-Day Moving Average of $10.52iCAD (NASDAQ:ICAD) Stock Price Passes Above 200-Day Moving Average of $10.52
americanbankingnews.com - January 14 at 3:34 AM
iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event - GlobeNewswireiCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event - GlobeNewswire
globenewswire.com - January 6 at 11:48 PM
iCAD (NASDAQ:ICAD) Stock Price Up 5.5%iCAD (NASDAQ:ICAD) Stock Price Up 5.5%
americanbankingnews.com - January 6 at 11:02 PM
iCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event - Yahoo FinanceiCAD to Participate in the LifeSci Partners 10th Annual Healthcare Corporate Access Event - Yahoo Finance
finance.yahoo.com - January 6 at 6:25 PM
iCAD, Inc. (NASDAQ:ICAD) Receives Average Rating of "Buy" from BrokeragesiCAD, Inc. (NASDAQ:ICAD) Receives Average Rating of "Buy" from Brokerages
americanbankingnews.com - January 3 at 5:44 AM
iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption - Yahoo FinanceiCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption - Yahoo Finance
finance.yahoo.com - December 30 at 12:24 AM
iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption - GlobeNewswireiCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption - GlobeNewswire
globenewswire.com - December 29 at 7:23 PM
iCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical AdoptioniCAD Announces Renowned Neuro-Oncologist Santosh Kesari, MD, PhD to Lead Post-Market Study for Treatment of Recurrent Glioblastoma (GBM) with FDA-cleared Xoft Brain IORT Technology to Support Clinical Adoption
finance.yahoo.com - December 29 at 7:23 PM
What Percentage Of iCAD, Inc. (NASDAQ:ICAD) Shares Do Insiders Own? - Yahoo FinanceWhat Percentage Of iCAD, Inc. (NASDAQ:ICAD) Shares Do Insiders Own? - Yahoo Finance
finance.yahoo.com - December 23 at 10:35 AM
Is ICAD A Good Stock To Buy Now? - Yahoo FinanceIs ICAD A Good Stock To Buy Now? - Yahoo Finance
finance.yahoo.com - December 13 at 3:40 AM
Is ICAD A Good Stock To Buy Now?Is ICAD A Good Stock To Buy Now?
finance.yahoo.com - December 13 at 3:40 AM
Solis Mammography Adopts iCADs ProFound AI Platform Powered by Panorama with Short-Term Breast Cancer Risk Assessment Solution - GlobeNewswireSolis Mammography Adopts iCAD's ProFound AI Platform Powered by Panorama with Short-Term Breast Cancer Risk Assessment Solution - GlobeNewswire
globenewswire.com - December 10 at 6:40 PM
Solis Mammography Adopts iCAD’s ProFound AI Platform Powered by Panorama with Short-Term Breast Cancer Risk Assessment SolutionSolis Mammography Adopts iCAD’s ProFound AI Platform Powered by Panorama with Short-Term Breast Cancer Risk Assessment Solution
finance.yahoo.com - December 10 at 6:40 PM
AI-Enabled Medical Imaging Solutions Market Size To Be Worth USD 4,720.6 Million by 2027 | Emergen Research - Yahoo FinanceAI-Enabled Medical Imaging Solutions Market Size To Be Worth USD 4,720.6 Million by 2027 | Emergen Research - Yahoo Finance
finance.yahoo.com - December 9 at 4:18 PM
Should I Buy Ceragon Networks Ltd. (CRNT)? - Yahoo FinanceShould I Buy Ceragon Networks Ltd. (CRNT)? - Yahoo Finance
finance.yahoo.com - December 5 at 2:47 AM
iCAD Hosting Investor Webinar on Expanded ProFound AI Portfolio with New Breast Cancer Risk Assessment Solution - GlobeNewswireiCAD Hosting Investor Webinar on Expanded ProFound AI Portfolio with New Breast Cancer Risk Assessment Solution - GlobeNewswire
globenewswire.com - December 3 at 5:50 PM
iCAD Hosting Investor Webinar on Expanded ProFound AI Portfolio with New Breast Cancer Risk Assessment SolutioniCAD Hosting Investor Webinar on Expanded ProFound AI Portfolio with New Breast Cancer Risk Assessment Solution
finance.yahoo.com - December 3 at 5:50 PM
iCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020 - Yahoo FinanceiCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020 - Yahoo Finance
finance.yahoo.com - November 30 at 3:49 PM
iCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020 - GlobeNewswireiCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020 - GlobeNewswire
globenewswire.com - November 30 at 9:32 AM
iCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020iCAD Highlights Expanded Suite of Leading Breast Health AI Solutions at Virtual RSNA 2020
finance.yahoo.com - November 30 at 9:32 AM
iCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online Congress - GlobeNewswireiCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online Congress - GlobeNewswire
globenewswire.com - November 25 at 7:04 PM
iCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online Congress - Yahoo FinanceiCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online Congress - Yahoo Finance
finance.yahoo.com - November 25 at 8:59 AM
iCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online CongressiCAD Announces Promising Clinical Data to be Presented on Treatment of Early-Stage Breast and Gynecological Cancers at ESTRO 2020 Online Congress
finance.yahoo.com - November 25 at 8:59 AM
iCAD sold over 1000 licenses as a part of ProFound AI sales - Seeking AlphaiCAD sold over 1000 licenses as a part of ProFound AI sales - Seeking Alpha
seekingalpha.com - November 24 at 1:53 PM
iCAD Reports Over 1000 Licenses Sold as Part of ProFound AI Sales - GlobeNewswireiCAD Reports Over 1000 Licenses Sold as Part of ProFound AI Sales - GlobeNewswire
globenewswire.com - November 24 at 1:53 PM
iCAD Reports Over 1,000 Licenses Sold as Part of ProFound AI SalesiCAD Reports Over 1,000 Licenses Sold as Part of ProFound AI Sales
finance.yahoo.com - November 24 at 8:52 AM
Butt Sports, CSG, D Knights, K Stags, ICAD, M Eagles, R Jurana cruise in Ace Travel Saudi CupButt Sports, CSG, D Knights, K Stags, ICAD, M Eagles, R Jurana cruise in Ace Travel Saudi Cup
msn.com - November 11 at 1:49 PM
Analysts Have Made A Financial Statement On iCAD, Inc.s (NASDAQ:ICAD) Third-Quarter Report - Yahoo FinanceAnalysts Have Made A Financial Statement On iCAD, Inc.'s (NASDAQ:ICAD) Third-Quarter Report - Yahoo Finance
finance.yahoo.com - November 8 at 6:42 PM
Analysts Have Made A Financial Statement On iCAD, Inc.s (NASDAQ:ICAD) Third-Quarter ReportAnalysts Have Made A Financial Statement On iCAD, Inc.'s (NASDAQ:ICAD) Third-Quarter Report
finance.yahoo.com - November 8 at 1:29 PM
iCAD, Inc. (ICAD) CEO Michael Klein on Q3 2020 Results - Earnings Call Transcript - Seeking AlphaiCAD, Inc. (ICAD) CEO Michael Klein on Q3 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 8 at 8:28 AM
iCAD, Inc. to Host Earnings Call - Yahoo FinanceiCAD, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - November 5 at 7:18 PM
iCAD Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 - GlobeNewswireiCAD Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020 - GlobeNewswire
globenewswire.com - November 5 at 7:18 PM
iCAD, Inc. to Host Earnings CalliCAD, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 7:18 PM
iCAD Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020iCAD Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2020
finance.yahoo.com - November 5 at 7:18 PM
Asfaan, ICAD, Jed Gladiators triumph in Ace Travel Saudi CupAsfaan, ICAD, Jed Gladiators triumph in Ace Travel Saudi Cup
msn.com - November 3 at 12:07 PM
iCAD to Report Third Quarter 2020 Financial Results on Thursday, November 5 - Yahoo FinanceiCAD to Report Third Quarter 2020 Financial Results on Thursday, November 5 - Yahoo Finance
finance.yahoo.com - October 29 at 2:34 PM
iCAD to Report Third Quarter 2020 Financial Results on Thursday, November 5iCAD to Report Third Quarter 2020 Financial Results on Thursday, November 5
finance.yahoo.com - October 29 at 9:33 AM
FactMR: Brachytherapy Devices Market to Surpass a Valuation of US$ 2.1 Bn by 2030 end: Fact.MRFactMR: Brachytherapy Devices Market to Surpass a Valuation of US$ 2.1 Bn by 2030 end: Fact.MR
finanznachrichten.de - October 27 at 9:59 AM
New Research Presented at Virtual ASTRO Meeting Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers - GlobeNewswireNew Research Presented at Virtual ASTRO Meeting Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers - GlobeNewswire
globenewswire.com - October 23 at 6:55 PM
New Research Presented at Virtual ASTRO Meeting Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological CancersNew Research Presented at Virtual ASTRO Meeting Supports Xoft System for Treatment of Early-Stage Breast Cancer and Gynecological Cancers
finance.yahoo.com - October 23 at 6:55 PM
iCAD, Inc. (NASDAQ:ICAD): Are Analysts Optimistic?iCAD, Inc. (NASDAQ:ICAD): Are Analysts Optimistic?
finance.yahoo.com - October 22 at 12:57 PM
Matinas Reports Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking AlphaMatinas Reports Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha
seekingalpha.com - October 21 at 11:38 AM
iCAD Signs Distribution Agreement with Change Healthcare - GlobeNewswireiCAD Signs Distribution Agreement with Change Healthcare - GlobeNewswire
globenewswire.com - October 20 at 12:47 PM
iCAD Xoft radiotherapy shows survival improvement in recurrent brain tumors treatment - Seeking AlphaiCAD' Xoft radiotherapy shows survival improvement in recurrent brain tumors treatment - Seeking Alpha
seekingalpha.com - October 20 at 12:41 AM
New Data Supports iCADs Xoft Brain IORT as Feasible Treatment for Recurrent Glioblastoma - GlobeNewswireNew Data Supports iCAD's Xoft Brain IORT as Feasible Treatment for Recurrent Glioblastoma - GlobeNewswire
globenewswire.com - October 19 at 2:40 PM
New Data Supports iCAD’s Xoft Brain IORT as Feasible Treatment for Recurrent GlioblastomaNew Data Supports iCAD’s Xoft Brain IORT as Feasible Treatment for Recurrent Glioblastoma
finance.yahoo.com - October 19 at 9:29 AM
iCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal Cancers - GlobeNewswireiCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal Cancers - GlobeNewswire
globenewswire.com - October 16 at 8:30 AM
iCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal CancersiCAD Hosting Technology Innovation Webinar on the Evolving Landscape for Treating Patients with Brain, Breast, and Rectal Cancers
finance.yahoo.com - October 16 at 8:30 AM
iCAD Responds to CMS Finalized Radiation Oncology Alternative Payment ModeliCAD Responds to CMS' Finalized Radiation Oncology Alternative Payment Model
marketwatch.com - September 26 at 6:43 PM
This page was last updated on 1/19/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.